Genevieve V. Dall
305 Grattan St
Melbourne, VIC, Australia
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
High-throughput drug screening identifies EGFR/MAPK pathway targeting sensitivities in organoid models of ovarian carcinosarcoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 10, 2025
Equitable Access to Genomic Molecular Testing for Australian Cancer Patients: Insights from the Victorian Precision Oncology Summit.
Journal: Current oncology (Toronto, Ont.)
Published: June 24, 2024
A risk-reward examination of sample multiplexing reagents for single cell RNA-Seq.
Journal: Genomics
Published: June 25, 2023
Rare Epithelial Ovarian Cancers: Low Grade Serous and Mucinous Carcinomas.
Journal: Cold Spring Harbor perspectives in medicine
Published: June 05, 2023
Targeting homologous recombination deficiency in uterine leiomyosarcoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 14, 2023
Estrogen-induced immune changes within the normal mammary gland.
Journal: Scientific reports
Published: May 21, 2022
Interrogating the Genomic Landscape of Uterine Leiomyosarcoma: A Potential for Patient Benefit.
Journal: Cancers
Published: February 11, 2022
Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin.
Journal: Cancer research
Published: November 22, 2021
Molecular comparison of pure ovarian fibroma with serous benign ovarian tumours.
Journal: BMC research notes
Published: June 01, 2020
Parity reduces mammary repopulating activity but does not affect mammary stem cells defined as CD24 + CD29/CD49fhi in mice.
Journal: Breast cancer research and treatment
Published: May 23, 2020
Estrogen receptor subtypes dictate the proliferative nature of the mammary gland.
Journal: The Journal of endocrinology
Published: March 23, 2018
Last Updated: 09/26/2026